| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.9M | +8.6% | +4.1% |
| Cost of Revenue | $2.1M | -31.5% | -29.2% |
| Gross Profit | $3.8M | +62.5% | +41.7% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $2.7M | +27.9% | -0.4% |
| Operating Income | $659K | +499.5% | +225.9% |
| Pre-tax Income | $755K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.8M | -5.4% | -11.5% |
| Accounts Receivable | $306K | +236.8% | +936.9% |
| Current Assets | $40.2M | -5.7% | +7.0% |
| Total Assets | $47.9M | +0.9% | +10.8% |
| Current Liabilities | $30.8M | +1.1% | +6.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | — |
| Investing Cash Flow | $1.4M | — | — |
| Financing Cash Flow | $2.5M | — | — |
| +216.3% |
| Net Income | $755K | +278.2% | +216.3% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| $31.5M |
| +0.6% |
| +6.3% |
| Stockholders' Equity | $16.4M | +1.1% | +19.9% |